Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 2,134 |
|
|||||
| News | - | ||||||
| Day High | 2.08 | Low High |
|||||
| Day Low | 1.90 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoMed Therapeutics Ltd | GDTC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.16 | -7.77% | 1.90 | 00:00:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.07 | 1.90 | 2.08 | 1.90 | 2.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 29 | 2,134 | $ 1.98 | $ 4,221 | - | 1.90 - 9.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 4 | $ 1.99 | USD |
CytoMed Therapeutics Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 21.91M | 11.53M | - | 518k | -4.13M | -0.36 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CytoMed Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GDTC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.095 | 2.095 | 1.90 | 2.04 | 5,935 | -0.195 | -9.31% |
| 1 Month | 2.10 | 2.169 | 1.90 | 2.06 | 2,866 | -0.20 | -9.52% |
| 3 Months | 2.28 | 2.48 | 1.90 | 2.11 | 4,760 | -0.38 | -16.67% |
| 6 Months | 3.38 | 5.50 | 1.90 | 3.76 | 30,482 | -1.48 | -43.79% |
| 1 Year | 2.97 | 9.25 | 1.90 | 5.15 | 118,715 | -1.07 | -36.03% |
| 3 Years | 4.00 | 9.25 | 1.90 | 4.88 | 124,986 | -2.10 | -52.50% |
| 5 Years | 4.00 | 9.25 | 1.90 | 4.88 | 124,986 | -2.10 | -52.50% |
CytoMed Therapeutics Description
| CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. |
